Vir Biotechnology (VIR) Return on Sales (2018 - 2026)

Vir Biotechnology's Return on Sales history runs 9 years deep, the most recent figure standing at 43.34% for Q1 2026.

• In Q1 2026, Return on Sales fell 4294.0% year-over-year to 43.34%; the TTM figure through Mar 2026 stood at 0.07% (up 21.0% YoY), while the FY2025 annual figure was 0.06%, up 1.0% from the prior year.
• Return on Sales came in at 43.34% for Q1 2026 at Vir Biotechnology, down from 0.01% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 0.0% in Q3 2022 to a low of 43.34% in Q1 2026.
• A 5-year average of 3.19% and a median of 0.08% in 2024 frame the typical range for Return on Sales.
• Across the five-year window, Return on Sales jumped 86 bps in 2022 and slumped 4294 bps in 2026, its largest moves.
• Vir Biotechnology's Return on Sales stood at 0.02% in 2022, then plunged by 236 bps to 0.07% in 2023, then decreased by 22 bps to 0.08% in 2024, then surged by 92 bps to 0.01% in 2025, then plunged by 646871 bps to 43.34% in 2026.
• According to Business Quant data, Return on Sales over the past three periods registered 43.34%, 0.01%, and 6.8% for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison